Quantcast

Latest PAREXEL International Corporation Stories

2014-08-06 16:29:37

BOSTON, Aug. 6, 2014 /PRNewswire/ -- Fourth Quarter Fiscal Year 2014 Results (compared to Fourth Quarter Fiscal Year 2013) -- 10.2% growth in consolidated service revenue to $510.6 million -- GAAP operating margin of 11.5%; adjusted operating margin of 11.2% (up 260 basis points) -- GAAP diluted earnings per share of $0.70 grew 34.6%; adjusted earnings per share of $0.65 grew 30.0% -- Net new business wins of $592.5 million; net book-to-bill...

2014-07-10 12:29:55

BOSTON, July 10, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2014 on Wednesday, August 6(th), 2014 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PR Newswire website at www.prnewswire.com. PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Thursday, August 7(th), 2014 to discuss the results....

2014-07-01 16:30:25

BOSTON, July 1, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" or the "Company"), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services ("ATLAS"), a provider of clinical research services in Turkey, the Middle East, and North Africa. ATLAS provides services across all phases of clinical development and has therapeutic expertise in Oncology, Hematology,...

2014-06-24 16:24:47

BOSTON, June 24, 2014 /PRNewswire/ -- In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has reconfirmed its forward-looking guidance for the fourth quarter of Fiscal Year 2014 (ending June 30, 2014), and for all of Fiscal Year 2014. This guidance was previously issued in a press release on April 29, 2014. The Company also issued guidance for Fiscal Year 2015 for the first time. The guidance takes into account a number of...

2014-06-23 08:27:17

Company recognized by Foundation of Medical Professionals Alliance in Taiwan BOSTON and TAIPEI, Taiwan, June 23, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named the 2014 Best Performing CRO in Taiwan for its innovative drug development strategies and healthcare industry leadership. PAREXEL received the award in May from the Foundation of Medical Professionals Alliance in Taiwan...

2014-06-19 08:28:01

International recognition for driving business performance through effective employee engagement BOSTON, June 19, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has won a 2014 Gold Quill Merit Award from the International Association of Business Communicators (IABC). The award recognizes achievement in driving business performance and employee engagement through successful communication...

2014-06-17 12:28:23

BOSTON, June 17, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Wednesday, June 25, 2014, from 8:30 a.m. to 12:30 p.m. (EDT). All interested parties are invited to listen as Chairman and Chief Executive Officer Josef von Rickenbach, Senior Vice President and Chief Financial Officer Ingo Bank and five additional members of the...

2014-06-16 12:29:31

Latest RTSM technology features standardized study components for faster implementation and greater design flexibility BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of a new version of its industry standard ClinPhone(®) RTSM services designed to help clients start clinical trials more quickly. The leading edge randomization and trial supply management (RTSM) solution...

2014-06-16 08:29:13

BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that it has entered into an Accelerated Share Repurchase (ASR) agreement with Goldman Sachs & Co. to repurchase an aggregate of $150 million of the Company's common stock. The ASR is part of the Company's share repurchase program authorizing the repurchase of up to $150 million, as originally announced on June 2, 2014. Under the ASR agreement, PAREXEL will receive approximately...

2014-06-11 12:28:40

BOSTON, June 11, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Wells Fargo Healthcare Conference in Boston. James Winschel, Executive Vice President, will be discussing business developments at 9:30 a.m. EDT on Wednesday, June 18, 2014. A live webcast of the discussion will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page,...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related